Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
16.51
-2.36 (-12.51%)
At close: Oct 10, 2025, 4:00 PM EDT
16.31
-0.20 (-1.21%)
After-hours: Oct 10, 2025, 7:46 PM EDT

Lyell Immunopharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
0.060.060.1384.6810.657.76
Upgrade
Revenue Growth (YoY)
11.11%-53.08%-99.85%695.15%37.31%1080.52%
Upgrade
Gross Profit
0.060.060.1384.6810.657.76
Upgrade
Selling, General & Admin
50.1252.0466.98117.3189.0646.88
Upgrade
Research & Development
166.47258.79182.95159.19138.69182.24
Upgrade
Other Operating Expenses
0.354.612.794.752.329.43
Upgrade
Total Operating Expenses
216.9365.43252.72281.25230.07238.56
Upgrade
Operating Income
-356.16-358.76-247.01-187.06-214.78-211.94
Upgrade
Interest Income
18.0224.0723.457.051.175.94
Upgrade
Other Non-Operating Income (Expense)
6.74-8.31-11.08-3.11-36.611.53
Upgrade
Total Non-Operating Income (Expense)
24.7615.7612.383.94-35.447.47
Upgrade
Pretax Income
-331.4-342.99-234.63-183.12-250.22-204.47
Upgrade
Net Income
-331.4-342.99-234.63-183.12-250.22-204.47
Upgrade
Net Income Attributable to Preferred Dividends
-----3.58
Upgrade
Net Income to Common
-331.4-342.99-234.63-183.12-250.22-204.47
Upgrade
Shares Outstanding (Basic)
1413131271
Upgrade
Shares Outstanding (Diluted)
1413131271
Upgrade
Shares Change (YoY)
11.19%4.18%1.58%81.79%925.18%144.21%
Upgrade
EPS (Basic)
-24.29-26.20-18.60-14.80-36.80-313.80
Upgrade
EPS (Diluted)
-24.29-26.20-18.60-14.80-36.80-313.80
Upgrade
Free Cash Flow
-172-162.86-166.38-193.83-191.75-212.36
Upgrade
Free Cash Flow Per Share
-12.21-12.46-13.26-15.69-28.22-320.34
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-593598.33%-588122.95%-190006.15%-220.89%-2016.68%-2732.56%
Upgrade
Profit Margin
-552328.33%-562285.25%-180486.15%-216.24%-2349.47%-2636.31%
Upgrade
FCF Margin
-286661.67%-266980.33%-127984.62%-228.89%-1800.50%-2737.94%
Upgrade
EBITDA
-339.88-339.12-226.76-169.04-201.15-207.64
Upgrade
EBITDA Margin
-566461.67%-555940.98%-174429.23%-199.61%-1888.75%-2677.19%
Upgrade
EBIT
-356.16-358.76-247.01-187.06-214.78-211.94
Upgrade
EBIT Margin
-593598.33%-588122.95%-190006.15%-220.89%-2016.68%-2732.56%
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q